Skip to main content

Series D Pharmaceutical Companies

Explore 26 pharmaceutical startups that raised series d funding. Access verified founder contact information and fundraising data.

Total Companies
26
Total Funding
$2.6B
Avg Funding
$102.8M
Cities
21

Export 26 Series D Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$160.0M
raised

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

Sep 2022
Series D

Founder Contacts

30,000+ verified contacts

München, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

Aug 2024
Series D

Founder Contacts

30,000+ verified contacts

New York, United States
$55.1M
raised

Inspirna is a biotechnology company developing drugs for the treatment of cancer.

Jul 2022
Series D

Founder Contacts

30,000+ verified contacts

New York, United States
$372.0M
raised

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

Jun 2024
Series D

Founder Contacts

30,000+ verified contacts

Tokyo, Japan
$31.2M
raised

SDP Japan is a procurement and sales of surgical components, pharmaceuticals, and consumables.

Jun 2025
Series D

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$69.6M
raised

BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.

May 2023
Series D

Founder Contacts

30,000+ verified contacts

New York, United States
$50.0M
raised

Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.

Apr 2026
Series D

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$19.8M
raised

Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Mar 2026
Series D

Founder Contacts

30,000+ verified contacts

New York, United States
$115.0M
raised

ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.

Feb 2026
Series D

Founder Contacts

30,000+ verified contacts

Boulder, United States
$150.0M
raised

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

Sep 2025
Series D

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Seattle, United States
$100.0M
raised

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Jul 2025
Series D

Founder Contacts

30,000+ verified contacts

Aliso Viejo, United States
$75.0M
raised

Spyglass Pharma provides medicine for ophthalmic diseases.

Jun 2025
Series D

Founder Contacts

30,000+ verified contacts

Ann Arbor, United States
$65.0M
raised

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

Sep 2024
Series D

Founder Contacts

30,000+ verified contacts

Zurich, Switzerland
$59.0M
raised

SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.

Jun 2024
Series D

Founder Contacts

30,000+ verified contacts

Montreal, Canada
$80.0M
raised

DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

Sep 2023
Series D

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Seongnam, South Korea
$21.9M
raised

1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.

Jan 2026
Series D

Founder Contacts

30,000+ verified contacts

North Andover, United States
$11.0M
raised

OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.

Dec 2021
Series D

Founder Contacts

30,000+ verified contacts

Chicago, United States
$270.0M
raised

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Nov 2022
Series D

Founder Contacts

30,000+ verified contacts

Emeryville, United States
$14.7M
raised

TruTag Technologies, Inc. provides product authentication and brand protection solutions.

Nov 2021
Series D

Founder Contacts

30,000+ verified contacts

New York, United States
$140.0M
raised

BlinkRx is a prescription access platform that connects patients to branded medications, ensuring transparent pricing and home delivery.

Nov 2024
Series D

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Allschwil, Switzerland
$181.4M
raised

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

Nov 2024
Series D

Founder Contacts

30,000+ verified contacts

Naxxar, Malta
$15.6M
raised

Mint Health is a pharmaceutical product distributor and wholesaler.

Nov 2021
Series D

Founder Contacts

30,000+ verified contacts

Ponte Vedra, United States
$68.0M
raised

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.

Oct 2024
Series D

Founder Contacts

30,000+ verified contacts

Hayward, United States
$142.0M
raised

Truepill provides an API-connected healthcare infrastructure designed to revolutionize the patient experience.

Oct 2021
Series D

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$304.0M
raised

Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.

Oct 2021
Series D

Founder Contacts

30,000+ verified contacts

Showing 1 to 25 of 26 companies

Ready to Connect with Series D Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 26 series d pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked